Merck & Co. Inc.
For the period ended Dec 31, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
MRK$146.73-0.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Insider Trading Arrangements
During the three months ended December 31, 2024, none of the Company’s directors or executive officers adopted orterminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.